These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 1691811

  • 1. Randomized comparison of two chemotherapy, radiotherapy schemes for stage III and IV unresectable squamous cell carcinoma of the head and neck.
    Merlano M, Rosso R, Sertoli MR, Benasso M, Bacigalupo A, Ardizzoni A, Mereu P, Margarino G, Scala M, Vitale V.
    Laryngoscope; 1990 May; 100(5):531-5. PubMed ID: 1691811
    [Abstract] [Full Text] [Related]

  • 2. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD, Haffty BG, Son YH, Ross DA, Weinberger PM, Chung GG, Zelterman D, Burtness BA, Cooper DL.
    J Clin Oncol; 2004 Aug 01; 22(15):3061-9. PubMed ID: 15284256
    [Abstract] [Full Text] [Related]

  • 3. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy.
    Merlano M, Vitale V, Rosso R, Benasso M, Corvò R, Cavallari M, Sanguineti G, Bacigalupo A, Badellino F, Margarino G.
    N Engl J Med; 1992 Oct 15; 327(16):1115-21. PubMed ID: 1302472
    [Abstract] [Full Text] [Related]

  • 4. Multidrug chemotherapy (vincristine, bleomycin, and methotrexate [VBM]) with radiotherapy in stage III-IV squamous cell carcinoma of the head and neck.
    Rosso R, Merlano M, Sertoli MR, Campora E, Scarpati D, Borasi F, Pallestrini E.
    Cancer Treat Rep; 1984 Oct 15; 68(7-8):1019-21. PubMed ID: 6204753
    [Abstract] [Full Text] [Related]

  • 5. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R, López-Pousa A, Martínez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Martí JL, Lobo F, Pastor P, Valentí V, Belón J, Sánchez MA, Chaib C, Pallarés C, Antón A, Cervantes A, Paz-Ares L, Cortés-Funes H.
    J Clin Oncol; 2005 Dec 01; 23(34):8636-45. PubMed ID: 16275937
    [Abstract] [Full Text] [Related]

  • 6. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Katori H, Tsukuda M, Watai K.
    Cancer Chemother Pharmacol; 2007 Aug 01; 60(3):399-406. PubMed ID: 17096160
    [Abstract] [Full Text] [Related]

  • 7. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R, Sonis S, Posner M, Wirth L, Costello R, Braschayko P, Allen A, Mahadevan A, Flynn J, Burke E, Li Y, Tishler RB.
    Cancer; 2009 Oct 01; 115(19):4514-23. PubMed ID: 19634161
    [Abstract] [Full Text] [Related]

  • 8. [Chemotherapy or chemotherapy and radiotherapy in advanced head and neck tumors. A prospective, randomized study comparing the 2 therapeutic modalities].
    Klima A, von Ilberg C, Bergmann L, Zoubek A, Klippstein T, Mitrou PS, Szepesi S.
    HNO; 1987 Feb 01; 35(2):78-83. PubMed ID: 2437086
    [Abstract] [Full Text] [Related]

  • 9. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.
    Recloux P, Dodion PF, Andry G, Chantrain G, Dor P, Buyse M, Van Houtte P, Lemort M, Haesendonck P, Larsimont D.
    Eur J Surg Oncol; 1989 Dec 01; 15(6):568-74. PubMed ID: 2480922
    [Abstract] [Full Text] [Related]

  • 10. Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: a phase III study.
    Merlano M, Rosso R, Sertoli MR, Bonelli L, Margarino G, Grimaldi A, Benasso M, Gardin G, Corvó R, Scarpati D.
    J Clin Oncol; 1988 Apr 01; 6(4):627-32. PubMed ID: 2451713
    [Abstract] [Full Text] [Related]

  • 11. Patterns of failure in patients with locally advanced head and neck cancer treated postoperatively with irradiation or concomitant irradiation with Mitomycin C and Bleomycin.
    Zakotnik B, Budihna M, Smid L, Soba E, Strojan P, Fajdiga I, Zargi M, Oblak I, Lesnicar H.
    Int J Radiat Oncol Biol Phys; 2007 Mar 01; 67(3):685-90. PubMed ID: 17197122
    [Abstract] [Full Text] [Related]

  • 12. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Katori H, Tsukuda M, Taguchi T.
    Cancer Chemother Pharmacol; 2007 May 01; 59(6):789-94. PubMed ID: 17053926
    [Abstract] [Full Text] [Related]

  • 13. [Randomized trial of initial chemotherapy in 151 locally advanced carcinoma of the cervix (T2b-N1, T3b, MO)].
    Chauvergne J, Rohart J, Héron JF, Aymé Y, Berlié J, Fargeot P, George M, Lebrun-Jezekova D, Pigneux J, Chenal C.
    Bull Cancer; 1990 May 01; 77(10):1007-24. PubMed ID: 2249011
    [Abstract] [Full Text] [Related]

  • 14. Combined radiotherapy and CMF-B cytotoxic regimen in stage III-IV head and neck squamous cell carcinoma.
    Tatarek R, Merlano M, Rosso R, Corvò L.
    Chemioterapia; 1984 Oct 01; 3(5):330-2. PubMed ID: 6085287
    [Abstract] [Full Text] [Related]

  • 15. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA, Dimery IW, Lee JJ, Perez C, Hong WK, Lippman SM.
    Cancer J Sci Am; 1997 Oct 01; 3(2):92-9. PubMed ID: 9099459
    [Abstract] [Full Text] [Related]

  • 16. Neoadjuvant chemotherapy in early-stage and locally advanced small bulk squamous cell carcinoma of the oral cavity and oropharynx.
    Tichler T, Ramon Y, Rath P, Hendler S, Brenner HJ.
    Isr J Med Sci; 1988 Oct 01; 24(9-10):539-44. PubMed ID: 2462551
    [Abstract] [Full Text] [Related]

  • 17. Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck.
    Garden AS, Harris J, Vokes EE, Forastiere AA, Ridge JA, Jones C, Horwitz EM, Glisson BS, Nabell L, Cooper JS, Demas W, Gore E.
    J Clin Oncol; 2004 Jul 15; 22(14):2856-64. PubMed ID: 15254053
    [Abstract] [Full Text] [Related]

  • 18. Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer.
    Panasci L, Gravenor D, Black M, Frenkiel S, Margolese R.
    Cancer Treat Rep; 1985 Sep 15; 69(9):1015-7. PubMed ID: 2411401
    [Abstract] [Full Text] [Related]

  • 19. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH, Mailliard JA, Suman VJ, Edmonson JH, Creagan ET, Nair S, Levitt R, Kugler JW.
    Cancer; 2002 Apr 15; 94(8):2224-31. PubMed ID: 12001121
    [Abstract] [Full Text] [Related]

  • 20. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma.
    Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Calais G.
    J Clin Oncol; 2004 Jan 01; 22(1):69-76. PubMed ID: 14657228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.